These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38860522)

  • 1. AKT1 Promotes Tumorigenesis and Metastasis by Directly Phosphorylating Hexokinases.
    Yu Y; Wang S; Wang Y; Zhang Q; Zhao L; Wang Y; Wu J; Han L; Wang J; Guo J; Xue J; Dong F; Zhang JH; Zhang L; Liu Y; Shi G; Zhang X; Li Y; Li J
    J Cell Biochem; 2024 Aug; 125(8):e30613. PubMed ID: 38860522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis.
    Zhang J; Wang S; Jiang B; Huang L; Ji Z; Li X; Zhou H; Han A; Chen A; Wu Y; Ma H; Zhao W; Zhao Q; Xie C; Sun X; Zhou Y; Huang H; Suleman M; Lin F; Zhou L; Tian F; Jin M; Cai Y; Zhang N; Li Q
    Nat Commun; 2017 Jan; 8():13732. PubMed ID: 28054552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPI1 involvement in malignant melanoma pathogenesis by regulation of HK2 through the AKT1/mTOR pathway.
    Liu C; Qiu X; Gao J; Gong Z; Zhou X; Luo H; Geng X
    J Cell Mol Med; 2023 Sep; 27(18):2675-2683. PubMed ID: 37539493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
    Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
    BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
    Xu S; Herschman HR
    Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.
    Kang M; Lee SM; Kim W; Lee KH; Kim DY
    Biochem Biophys Res Commun; 2019 Apr; 512(1):93-99. PubMed ID: 30871777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation.
    Li H; Lu S; Chen Y; Zheng L; Chen L; Ding H; Ding J; Lou D; Liu F; Zheng B
    Cell Signal; 2019 Jun; 58():99-110. PubMed ID: 30877036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.
    Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
    Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways.
    Yang S; Tang W; Azizian A; Gaedcke J; Ohara Y; Cawley H; Hanna N; Ghadimi M; Lal T; Sen S; Creighton CJ; Gao J; Putluri N; Ambs S; Hussain P
    Carcinogenesis; 2024 Aug; 45(8):582-594. PubMed ID: 38629149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
    Long W; Gong X; Yang Y; Yang K
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition.
    Tseng PL; Chen CW; Hu KH; Cheng HC; Lin YH; Tsai WH; Cheng TJ; Wu WH; Yeh CW; Lin CC; Tsai HJ; Chang HC; Chuang JH; Shan YS; Chang WT
    Oncotarget; 2018 Apr; 9(27):18949-18969. PubMed ID: 29721175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT/mTOR/HK2-mediated glycolysis.
    Huang J; Gao W; Liu H; Yin G; Duan H; Huang Z; Zhang Y
    Gene; 2020 Aug; 750():144681. PubMed ID: 32304784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
    Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
    FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
    Bustamante MF; Oliveira PG; Garcia-Carbonell R; Croft AP; Smith JM; Serrano RL; Sanchez-Lopez E; Liu X; Kisseleva T; Hay N; Buckley CD; Firestein GS; Murphy AN; Miyamoto S; Guma M
    Ann Rheum Dis; 2018 Nov; 77(11):1636-1643. PubMed ID: 30061164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells.
    Tian X; Liu D; Zuo X; Sun X; Wu M; Li X; Teng Y
    J Ovarian Res; 2022 Aug; 15(1):92. PubMed ID: 35953860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
    Xu S; Catapang A; Braas D; Stiles L; Doh HM; Lee JT; Graeber TG; Damoiseaux R; Shirihai O; Herschman HR
    Cancer Metab; 2018; 6():7. PubMed ID: 29988332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT1/HK2 Axis-mediated Glucose Metabolism: A Novel Therapeutic Target of Sulforaphane in Bladder Cancer.
    Huang L; He C; Zheng S; Wu C; Ren M; Shan Y
    Mol Nutr Food Res; 2022 Feb; 66(3):e2100738. PubMed ID: 34791822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1
    Xu S; Zhou T; Doh HM; Trinh KR; Catapang A; Lee JT; Braas D; Bayley NA; Yamada RE; Vasuthasawat A; Sasine JP; Timmerman JM; Larson SM; Kim Y; MacLeod AR; Morrison SL; Herschman HR
    Cancer Res; 2019 May; 79(10):2748-2760. PubMed ID: 30885978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma.
    Singh S; Lathoria K; Umdor SB; Singh J; Suri V; Sen E
    Cytokine; 2024 Apr; 176():156535. PubMed ID: 38325141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling.
    Wang B; Zhang X; Li ZS; Wei C; Yu RZ; Du XZ; He YJ; Ren Y; Zhen YW; Han L
    Cancer Lett; 2024 Mar; 585():216665. PubMed ID: 38290657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.